Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$836M |
| 2 |
Microsoft
MSFT
|
+$748M |
| 3 |
Cigna
CI
|
+$560M |
| 4 |
3M
MMM
|
+$558M |
| 5 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$535M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$568M |
| 2 |
Zoom
ZM
|
+$557M |
| 3 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$516M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$479M |
| 5 |
Unity
U
|
+$476M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.71% |
| 2 | Healthcare | 11.34% |
| 3 | Financials | 9.38% |
| 4 | Consumer Discretionary | 8.31% |
| 5 | Communication Services | 5.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Main Street Capital
MAIN
$5.54B
| $23.4M | ﹤0.01% |
696,465
+84,343
| +14% | +$3.47M |
|
|
AVDX
2027
DELISTED
AvidXchange
AVDX
| $23.4M | ﹤0.01% |
2,780,448
-25,356
| -0.9% | -$196K |
|
|
SEM
2028
DELISTED
Select Medical
SEM
| $23.4M | ﹤0.01% |
1,966,193
-32,526
| -2% | -$462K |
|
2029
WisdomTree Bloomberg US Dollar Bullish Fund
USDU
$458M
| $23.4M | ﹤0.01% |
784,405
+371,537
| +90% | +$10.7M |
|
|
NBIS
2030
Nebius Group N.V.
NBIS
$69.3B
| $23.3M | ﹤0.01% |
1,565,835
-149,303
| -9% | -$2.23M |
|
|
BSJO
2031
DELISTED
Invesco BulletShares 2024 High Yield Corporate Bond ETF
BSJO
| $23.3M | ﹤0.01% |
1,078,961
-921
| -0.1% | -$20.6K |
|
2032
Cohen & Steers REIT and Preferred and Income Fund
RNP
$984M
| $23.3M | ﹤0.01% |
1,202,983
+41,450
| +4% | +$948K |
|
2033
Sprout Social
SPT
$604M
| $23.3M | ﹤0.01% |
384,341
+264
| +0.1% | +$15.9K |
|
2034
Aaon
AAON
$7.23B
| $23.3M | ﹤0.01% |
648,186
-87,929
| -12% | -$3.39M |
|
2035
MGP Ingredients
MGPI
$389M
| $23.3M | ﹤0.01% |
219,096
-9,598
| -4% | -$1.03M |
|
2036
Schwab US Mid-Cap ETF
SCHM
$15.3B
| $23.3M | ﹤0.01% |
1,152,501
-472,743
| -29% | -$10.5M |
|
2037
Gildan
GIL
$10.6B
| $23.2M | ﹤0.01% |
820,687
-177,463
| -18% | -$5.3M |
|
|
BYM
2038
DELISTED
BlackRock Municipal Income Quality Trust
BYM
| $23.2M | ﹤0.01% |
2,114,005
+23,656
| +1% | +$300K |
|
2039
Goldman Sachs Equal Weight US Large Cap Equity ETF
GSEW
$2.07B
| $23.2M | ﹤0.01% |
434,786
-115,411
| -21% | -$6.8M |
|
2040
First Trust RiverFront Dynamic Developed International ETF
RFDI
$168M
| $23.2M | ﹤0.01% |
501,727
+183,271
| +58% | +$9.78M |
|
|
MMD
2041
MainStay MacKay DefinedTerm Municipal Opportunities Fund
MMD
$283M
| $23.1M | ﹤0.01% |
1,483,248
+123,793
| +9% | +$2.24M |
|
|
JOYY
2042
JOYY Inc
JOYY
$3.64B
| $23.1M | ﹤0.01% |
888,063
-62,214
| -7% | -$1.71M |
|
2043
Under Armour Class C
UA
$2.25B
| $23.1M | ﹤0.01% |
3,873,669
-4,466,734
| -54% | -$35M |
|
2044
Goldman Sachs MarketBeta US Equity ETF
GSUS
$3.32B
| $23.1M | ﹤0.01% |
473,213
+587
| +0.1% | +$31.8K |
|
2045
Robinhood
HOOD
$89.3B
| $23.1M | ﹤0.01% |
2,283,629
-1,869,122
| -45% | -$18M |
|
|
EVOP
2046
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $23M | ﹤0.01% |
692,072
+526,985
| +319% | +$16.3M |
|
|
MDRX
2047
DELISTED
Veradigm Inc. Common Stock
MDRX
| $23M | ﹤0.01% |
1,508,949
-256,665
| -15% | -$4.15M |
|
|
MZTI
2048
The Marzetti Company
MZTI
$3.22B
| $23M | ﹤0.01% |
152,802
+30,289
| +25% | +$4.5M |
|
2049
Silicon Laboratories
SLAB
$7.28B
| $22.9M | ﹤0.01% |
185,418
+43,930
| +31% | +$5.87M |
|
2050
Buckle
BKE
$2.31B
| $22.9M | ﹤0.01% |
721,768
-68,758
| -9% | -$2.16M |
|
Similar funds
Morgan Stanley's Q3 2022 Portfolio in Review
As of Q3 2022, Morgan Stanley held 8,241 positions worth $734B, down 4.8% from $770B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Morgan Stanley's Q3 2022 filing shows 197 new, 3,111 increased, 3,746 reduced and 238 closed positions. Its largest new stake was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M. The largest sale was Amgen, an estimated $568M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q3 2022 buy was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M.
- Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $836M increase.
- Morgan Stanley's biggest Q3 2022 reduction was Amgen, cutting an estimated $568M.
- Morgan Stanley fully exited Coherent Inc in Q3 2022, selling an estimated $104M.
- Morgan Stanley's ten largest holdings make up 16% of its $734B portfolio in Q3 2022.
- Morgan Stanley opened 197 new positions and closed 238 in Q3 2022.
- Morgan Stanley's portfolio value fell 4.8% quarter-over-quarter to $734B.
Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.